PRICE T ROWE ASSOCIATES INC /MD/

Position in EYPT — EyePoint, Inc.

CIK 80255 BALTIMORE, MD

Position in EYPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,368,118

-$323,135 QoQ

Shares Held

106,138

+14.7% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 95.16290112871921.ToString("F0")% Shared 0.ToString("F0")% None 4.837098871280785.ToString("F0")%

Healthcare · as of Mar 31, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. EYPT ranks #147 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	3,374,955	$2,464,560,888
2	REGN	Regeneron Pharmaceuticals, Inc.	2,177,527	$1,682,444,460
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,760,122	$785,964,877
4	INSM	INSMED Inc	3,092,807	$505,735,799
5	KYMR	Kymera Therapeutics, Inc.	6,060,847	$504,807,946
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,432,748	$474,053,330
7	ASND	Ascendis Pharma A/S	1,530,345	$350,035,811
8	RVMD	Revolution Medicines, Inc.	3,232,213	$314,332,713

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,368,118	106,138	+14.7%	Shares	Defined	2026-05-15
2025-12-31	$1,691,253	92,570	+13.0%	Shares	Defined	2026-02-17
2025-09-30	$1,166,426	81,912	-2.1%	Shares	Defined	2025-11-14
2025-06-30	$787,701	83,709	-93.8%	Shares	Defined	2025-08-14
2025-03-31	$7,338,755	1,354,014	-36.9%	Shares	Sole	2025-05-14
2024-12-31	$15,978,364	2,144,747	-13.9%	Shares	Sole	2025-02-14
2024-09-30	$19,912,781	2,492,213	-0.4%	Shares	Sole	2024-11-14
2024-06-30	$21,770,626	2,502,371	+1.5%	Shares	Defined	2024-08-14
2024-03-31	$50,968,395	2,465,815	-2.3%	Shares	Sole	2024-05-15
2023-12-31	$58,299,689	2,522,704	+83.6%	Shares	Sole	2024-02-16
2023-09-30	$10,981,024	1,374,346	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.